Global Imaging biomarkers market 2014-2018

DUBLIN, 25 March of 2014/PRNewswire /-

Research  and  markets (http://www.researchandmarkets.com/research/tp3h3r/global_imaging) has announced the addition of the report "Global Imaging biomarkers market 2014-2018" to its offer.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Prognosis of analysts of the market Global Imaging biomarkers to grow at a CAGR of 15.09 percent in the period 2013-2018. One of the key factors contributing to this growth of the market is the increasing prevalence of cancer. Biomarkers of image Global market has also witnessed the emergence of personalized medicine. However, the poor regulatory and reimbursement systems could pose a challenge to the growth of this market.

The report, Global Imaging biomarkers market 2014-2018, based on an in-depth analysis of the market with input from industry experts. The report covers the market in the Americas and the regions EMEA and APAC; also covers the landscape of market Global Imaging biomarkers and their prospects for growth in the coming years. The report also includes a discussion of the main vendors operating in this market.

Biomarkers of image Global market has witnessed an increase in the number of partnerships formed between the organizations strategic. Mergers and acquisitions help organizations quickly grow, expand their business processes and gain more market share. The introduction of technologies in small and medium-sized enterprises is leading to major pharmaceutical and biotech companies to form strategic alliances with these smaller companies to identify different biomarkers of image.

The increase in alliances is resulting in an increase in the base application for imaging biomarkers in domains of discovery and diagnosis of drugs. For example, in 2012, Genomic Health Inc. and OncoMed Pharmaceuticals announce a strategic alliance for the research of biomarkers and discovery through the process of next-generation sequencing.

According to the report, the use of imaging biomarkers in the field of drug discovery has increased considerably in recent years. The increase in the demand for imaging biomarkers is mainly due to its ability to be used in white discovery and validation, identification of proof-of-concept studies, toxicity profiles and disease mechanisms.

In addition, the report notes that one of the main challenges that hinder the growth of this market is the presence of poor regulatory and reimbursement systems. Reimbursement systems present in several countries and current regulators are not suitable for imaging Diagnostics based on biomarkers. The development of novel and useful image biomarkers is also a costly and time-consuming process of time.

The study was carried out with a combination of objective of primary data and secondary, including contributions from key players in the industry. The report contains a broad market and vendor landscape as well as a SWOT analysis of key suppliers.

Key  songs  covered: 

1. Executive summary

2. list of abbreviations

3. scope of the report

4 methodology of market research

5 introduction

6. market landscape

7. geographic segmentation

8 buying criteria

9 market growth drivers

10 drivers and its impact

11. the challenges of the market

12. the impact of drivers and challenges

13. the trends of the market

14 trends and its impact

15 vendor landscape

16. key supplier analysis

17. other reports in this series

Companies  mentioned:

Abbott LaboratoriesAgilent Technologies Inc.Affymetrix Inc.Bio-Rad Laboratories Inc.F. Hoffmann the Roche Ltd.Gen-Probe Inc.Siemens Healthcare.
For more information visit http://www.researchandmarkets.com/research/tp3h3r/global_imaging

Media  contact: Laura Wood, + 353-1-481-1716, press@researchandmarkets.net

Markets and supply research